Skip to main content

AdaptHealth Corp.

corporate_fare Company Profile

AdaptHealth Corp.

AHCO·NASDAQ·Life Sciences·CIK 0001725255

AdaptHealth Corp. is a national leader in providing patient-centered, healthcare-at-home solutions, including home medical equipment, medical supplies, and related services. The company operates through four reportable segments. The Sleep Health segment provides sleep therapy equipment, supplies, and related services, such as continuous positive airway pressure and BiLevel services, for obstructive sleep apnea. The Respiratory Health segment offers oxygen and home mechanical ventilation equipment and supplies, along with chronic therapy services, for respiratory diseases like chronic obstructive pulmonary disease and chronic respiratory failure. The Diabetes Health segment provides medical devices, including continuous glucose monitors and insulin pumps, and related services for diabetes treatment. The Wellness at Home segment delivers home medical equipment and services to patients in their homes, including those discharged from acute care and other facilities, providing essential medical supplies and durable medical equipment for patients adjusting to new lifestyles or managing complex disease states. AdaptHealth services beneficiaries of Medicare, Medicaid, and commercial insurance payors. As of December 31, 2025, AdaptHealth serviced approximately 4.3 million patients annually across all 50 states through its network of approximately 640 locations in 48 states. The company delivers products directly to a patient's home upon discharge from a hospital or receipt of a physician/medical referral.

AdaptHealth Corp. (NASDAQ:AHCO) is a publicly traded company in the Life Sciences sector. Wiseek monitors AHCO SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • AdaptHealth Sells Diabetes Unit to Cardinal Health for $235M Cash
  • AdaptHealth Sells Diabetes Health Business to Cardinal Health for $235M Cash
  • AdaptHealth to Redeem $325M Senior Notes, Leveraging Existing Credit Facility
  • AdaptHealth Discloses Material Cybersecurity Breach, Patient Data and Billing Passwords Stolen
  • AdaptHealth Discloses Material Cybersecurity Incident Involving Patient Data

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$3.24B
Net Income
-$70.79M
Diluted EPS
-$0.52
Op. Cash Flow
$601.77M
Free Cash Flow
$219.38M
Gross Profit
$609.2M
Operating Income
$90.87M
Cash & Equivalents
$106.14M
Total Debt
$1.74B
Debt / Equity
1.14×
Net Margin
-2.2%
Shares Outstanding
135.45M sh
Source: 10-K · filed 2026-02-24 · accession 0001628280-26-011213
Browse all tickers starting with A →
$12.01 +0.79% today
52-week range · as of 2026-07-20 $8.51 – $13.43
Market cap
$1.53B
Volume
771.7K (0.5× avg)
3-mo avg 1.4M
Live data · 2026-07-29 13:18 UTC · Pre-market

show_chartPrice Chart

Loading chart...

feed AHCO - Latest Insights

AHCO
Jul 20, 2026, 4:37 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $11.17
Real-time Price: $12.01 info
Change: +$0.840 (+8%) info
Market Cap: $1.527B info
AHCO
Jul 20, 2026, 4:35 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $11.17
Real-time Price: $12.01 info
Change: +$0.840 (+8%) info
Market Cap: $1.527B info
AHCO
Jul 07, 2026, 4:45 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $10.15
Real-time Price: $12.01 info
Change: +$1.86 (+18%) info
Market Cap: $1.527B info
AHCO
Jul 02, 2026, 4:57 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $10.00
Real-time Price: $12.01 info
Change: +$2.01 (+20%) info
Market Cap: $1.527B info
AHCO
Jul 02, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $10.76
Real-time Price: $12.01 info
Change: +$1.25 (+12%) info
Market Cap: $1.527B info
AHCO
May 05, 2026, 4:21 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $11.75
Real-time Price: $12.01 info
Change: +$0.260 (+2%) info
Market Cap: $1.527B info
AHCO
May 05, 2026, 7:07 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $12.40
Real-time Price: $12.01 info
Change: -$0.390 (-3%) info
Market Cap: $1.527B info
AHCO
May 05, 2026, 7:07 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $12.51
Real-time Price: $12.01 info
Change: -$0.500 (-4%) info
Market Cap: $1.527B info
AHCO
Apr 28, 2026, 4:33 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $13.38
Real-time Price: $12.01 info
Change: -$1.37 (-10%) info
Market Cap: $1.527B info
AHCO
Apr 13, 2026, 8:11 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $12.15
Real-time Price: $12.01 info
Change: -$0.140 (-1%) info
Market Cap: $1.527B info
AHCO
Mar 23, 2026, 6:25 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $10.37
Real-time Price: $12.01 info
Change: +$1.64 (+16%) info
Market Cap: $1.527B info
AHCO
Mar 12, 2026, 9:10 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $9.75
Real-time Price: $12.01 info
Change: +$2.26 (+23%) info
Market Cap: $1.527B info
AHCO
Feb 24, 2026, 5:09 PM EST
Filing Type: 10-K
Importance Score:
8
Price at Filing: $8.86
Real-time Price: $12.01 info
Change: +$3.15 (+36%) info
Market Cap: $1.527B info
AHCO
Feb 24, 2026, 7:11 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $10.37
Real-time Price: $12.01 info
Change: +$1.64 (+16%) info
Market Cap: $1.527B info